Polymorphism of the Androgen Receptor Gene Is Associated with Male Pattern Baldness

    Justine A. Ellis, Margaret Susanne Stebbing, Stephen Harrap
    TLDR Male pattern baldness is linked to specific genetic variations in the androgen receptor gene.
    The study found a significant association between male pattern baldness (MPB) and polymorphisms in the androgen receptor (AR) gene. Researchers observed that the StuI restriction site was present in 98.1% of young bald men and 92.3% of older bald men, compared to 76.6% of non-bald men, indicating a strong genetic link. Additionally, shorter CAG and GGC triplet repeats were more common in bald men. These findings suggested that these genetic markers were closely linked to a functional variant necessary for the polygenic determination of MPB, highlighting the complexity of MPB involving both genetic predispositions and androgen receptor activity.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 1000+ results

      community My Theory Of Androgenic Alopecia

      in Research/Science  19 upvotes 4 months ago
      Hair loss is linked to cellular physiology and the IGF-1 to TGF-B1 ratio, not just androgen sensitivity. The theory lacks evidence, while finasteride and minoxidil are effective treatments.

      community Occipitalis Muscle Tension Theory

      in Treatment  7 upvotes 1 month ago
      Scalp tension from the occipitalis muscle is theorized to contribute to hair loss, but most believe DHT and genetics are the main causes. Treatments like finasteride and minoxidil are considered more effective than addressing scalp tension.

      community Why does MPB only affect the scalp

      in Research/Science  14 upvotes 1 year ago
      Male pattern baldness (MPB) may be influenced by androgen receptors in scalp hair follicles and potentially poor blood flow. Transplanted hair is not immune to DHT, and factors like inflammation and scalp tension might also contribute to hair loss.

      community Breezula phase 3 results said to be released next month

      in Product  28 upvotes 1 year ago
      Breezula's phase 3 results are expected soon, with discussions on the effectiveness of androgen receptor antagonists like spironolactone and the potential of GT20029. Users express skepticism about new treatments and discuss the complexities of male pattern baldness, often relying on finasteride despite its side effects.

    Similar Research

    5 / 1000+ results